SCHEMBL22112684

SCHEMBL22112684

CCCOCn1c(Br)c(-c2ccc(F)cc2)c(Br)c1C(=O)OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 2/20 0.36
SLC6A4 P31645 1/20 0.36
HTR3A P46098 1/20 0.36
GCGR P47871 1/20 0.36
MAPT P10636 4/20 0.36
IKBKB O14920 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 2/20 0.35
MAPK8 P45983 2/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
TSHR P16473 1/20 0.34
ALOX12 P18054 1/20 0.34
HSD17B10 Q99714 1/20 0.34
GRIA2 P42262 1/20 0.34
GRIA4 P48058 1/20 0.34
CASP3 P42574 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22112683 0.87 THRB (0.38) SLC6A3SLC6A4HTR3AGCGRMAPT
SCHEMBL24309370 0.87 PTGS2 (0.35) SLC6A3SLC6A4HTR3AGCGRMAPT
SCHEMBL30725440 0.70 NPC1 (0.33) MAPTNPC1
SCHEMBL24309245 0.67 SLC6A3 (0.40) SLC6A3SLC6A4GCGRIKBKBKDM4E
SCHEMBL6371032 0.66 HTR3A (0.63) HTR3AGCGR
SCHEMBL6219192 0.66 HTR3A (0.63) HTR3AGCGR
SCHEMBL25277112 0.65 HTR3A (0.43) SLC6A3SLC6A4HTR3AGCGRMAPT
SCHEMBL22095437 0.64 SLC6A3 (0.48) SLC6A3SLC6A4HTR3AMAPTIKBKB
SCHEMBL22095713 0.64 TUBB4A (0.51) SLC6A3SLC6A4HTR3AGCGRMAPT
SCHEMBL25222265 0.63 HTR3A (0.39) SLC6A3SLC6A4HTR3AGCGRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020123994-A1 2-((5-(PHENYL)-PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)AMINO)-3-(PHENYL)PROPANOIC ACID DERIVATIVES AND RELATED COMPOUNDS AS MCL-1 ENZYME INHIBITORS FOR TREATING CANCER PRELUDE THERAPEUTICS, INCORPORATED (US) 2020-06-18 WO disclosed